Literature DB >> 7872366

Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry.

S S Deenitchina1, T Ando, S Okuda, N Kinukawa, H Hirakata, A Nagashima, M Fujishima.   

Abstract

Immune cell subsets, when measured by two-color flow cytometry in a population of 129 hemodialysis patients, showed significant variance from normal values. Lymphopenia, decreased absolute counts, and altered percentage values of immune cells were found. Increased proportions of CD3+, T cell receptor (TCR) alpha beta + cells and CD4+ T lymphocytes were present. An abnormally high percentage of a subset of activated TCR alpha beta + cells (alpha beta + DR+) was also seen in hemodialysis patients. The proportion of B lymphocytes was found to be significantly lower as compared with controls. Relative values for TCR gamma delta+cells, both for activated (gamma delta + DR+) and nonactivated (gamma delta + DR-) subsets, as well as for CD8+ lymphocytes and natural killer cells did not vary from those of normal controls. Also, the CD4+/CD8+ ratio showed no significant change. Analysis of absolute counts of the investigated immune cell populations revealed significantly decreased numbers for the majority of subsets, as a result of the preexisting lymphocytopenia, characteristic of end-stage renal disease. We conclude that profound quantitative alterations of immune cells, including TCR+T cells subsets, exist in hemodialysis patients. These account, at least in part, for the immune dysregulation associated with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7872366     DOI: 10.1159/000168802

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure.

Authors:  Takashi Orii; Tetsuro Takayama; Izumi Haga; Tatsuya Fukumori; Noritoshi Amada
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

2.  The effects of renal transplantation on circulating dendritic cells.

Authors:  D A Hesselink; L M B Vaessen; W C J Hop; W Schoordijk; J N M Ijzermans; C C Baan; W Weimar
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

3.  The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

4.  Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised.

Authors:  Marine Baron; Renata Belo; Dominique Cathelin; Lucia Moreira-Teixeira; Claire Cartery; Eric Rondeau; Laurent Mesnard; Maria Leite-de-Moraes
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

5.  The influence of haemodialysis on CD4+ T-cell counts in people living with human immunodeficiency virus with end-stage kidney disease.

Authors:  Melanie Pretorius; Estee Benade; June Fabian; Denise Lawrie; Elizabeth S Mayne
Journal:  South Afr J HIV Med       Date:  2020-12-21       Impact factor: 2.744

6.  Safety and efficacy of coronavirus disease-19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review.

Authors:  Neha Mehta; Sangam Shah; Kiran Paudel; Rajan Chamlagain; Santosh Chhetri
Journal:  Health Sci Rep       Date:  2022-06-16

7.  Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.

Authors:  Madeleine V Pahl; Sastry Gollapudi; Lili Sepassi; Pavan Gollapudi; Reza Elahimehr; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2009-08-14       Impact factor: 5.992

8.  Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.

Authors:  Eva Schrezenmeier; Leon Bergfeld; David Hillus; Joerg-Detlev Lippert; Ulrike Weber; Pinkus Tober-Lau; Irmgard Landgraf; Tatjana Schwarz; Kai Kappert; Ana-Luisa Stefanski; Arne Sattler; Katja Kotsch; Thomas Dörner; Leif Erik Sander; Klemens Budde; Fabian Halleck; Florian Kurth; Victor Max Corman; Mira Choi
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

9.  CD19+ B-Cells, a New Biomarker of Mortality in Hemodialysis Patients.

Authors:  María Molina; Luis M Allende; Luis E Ramos; Eduardo Gutiérrez; Daniel E Pleguezuelo; Eduardo R Hernández; Francisco Ríos; Cristina Fernández; Manuel Praga; Enrique Morales
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.